Copy to clipboard 
PBC Biomed entered a partnership agreement with curasan to develop innovative products in the field of musculoskeletal regeneration, to create an expanded offering of solutions for patients suffering from bone defects.
Dirk Dembski, CEO of curasan AG, said, “Curasan’s portfolio of products have been appreciated for decades by medical professionals around the globe. When it comes to regeneration of musculoskeletal defects, we are well known for quality, safety, and effectiveness. Partnering with PBC Biomed will support our efforts in further developing disruptive and innovative products. This collaboration significantly contributes to our mission of revolutionizing musculoskeletal healing.”
PBC Biomed is focused on accelerating medical innovation in the areas of bone and tissue healing through partnerships with healthcare professionals, academic institutions and medtech companies worldwide.
Paul Burke, Managing Partner at PBC Biomed, said, “PBC Biomed is delighted to join forces with curasan AG to support their ongoing focus of improving patient healing. We look forward to working alongside curasan to develop and commercialise innovative biomaterials for the treatment of bone defects.“
